徠木股份(603633.SH):公司立項TSN系統研發項目,產品落地後主要應用於自動駕駛領域
格隆匯7月4日丨徠木股份(603633.SH)在投資者互動平台表示,持續提高研發投入進行前沿技術研究及推進新技術在新產品開發中的應用使公司形成了較高的技術實力和創新能力。在汽車領域,公司共開發了2,000餘款汽車連接器及組件產品,產品已覆蓋智能駕駛艙系統、輔助駕駛系統、三電系統、域控制器系統等。公司以卓越品質和技術實力樹立了國內汽車電子連接器行業的嶄新標杆;在儲能、氫能源電池等領域,公司開發的新產品已通過測試認證,部分產品已經實現銷售。 2023年底,公司立項TSN系統研發項目,產品落地後主要應用於自動駕駛領域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.